Francesco De Rubertis

Insider Reports History

Location
Geneva
Signature
/s/ Marella Thorell, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francesco De Rubertis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Director Ordinary Shares 281,162 $2,238,050 $7.96 21 Mar 2022 Indirect

Insider Reports Filed by Francesco De Rubertis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 21 Mar 2022 2 $0 4 Director 23 Mar 2022, 16:36
CNTA Centessa Pharmaceuticals plc 02 Dec 2021 2 +$440,059 4 Director 06 Dec 2021, 16:31
CNTA Centessa Pharmaceuticals plc 30 Nov 2021 4 +$1,189,199 4 Director 02 Dec 2021, 16:24
CNTA Centessa Pharmaceuticals plc 26 Nov 2021 4 +$797,426 4 Director 30 Nov 2021, 16:26
CNTA Centessa Pharmaceuticals plc 27 May 2021 0 $0 3 Director 27 May 2021, 20:20
CNTA Centessa Pharmaceuticals plc 29 Jan 2021 8 +$33,249,998 4 Director 04 Jun 2021, 17:01